Uratuf 100mg/224mg Capsule belongs to the group of anti-cancer medicines indicated with calcium folinate for the first-line treatment of metastatic colorectal cancer. Colorectal cancer is a disease in which the cells in the colon or rectum grow out of control.

Uratuf 100mg/224mg Capsule contains Tegafur and Uracil, which work by interfering with the growth and multiplication of cancer cells. Thereby, it helps treat cancer.

In some cases, Uratuf 100mg/224mg Capsule may cause side effects such as diarrhoea, nausea, vomiting, and abdominal pain. Most of these side effects may not require medical attention and resolve gradually over time. Do not be reluctant to talk with your doctor if any of the side effects persist or worsen.

Do not take Uratuf 100mg/224mg Capsule if you are pregnant or breastfeeding. This medicine is not recommended for children as safety and effectiveness have not been established. Keep the doctor informed about your health condition and medications to rule out any side effects/interactions.

Uratuf 100mg/224mg Capsule belongs to the group of anti-cancer medicines indicated for the first-line treatment of metastatic colorectal cancer with calcium folinate. Uratuf 100mg/224mg Capsule contains Tegafur and Uracil, which work by interfering with the growth and multiplication of cancer cells. Thus, it helps treat cancer.

Do not take Uratuf 100mg/224mg Capsule if you are allergic to any of its components or if you are pregnant or breastfeeding. Consult the doctor immediately if you become pregnant during treatment with Uratuf 100mg/224mg Capsule. Uratuf 100mg/224mg Capsule is not recommended for children, paediatrics and adolescents. Inform the doctor if you experience symptoms of infection (fever or sudden unwell feeling), unexplained bleeding or bruising (bleeding gums, nose bleeds, rashes or blood spots on the skin), anaemia (tiredness and breathlessness) or conjunctivitis (sore and inflamed eyes). Let the doctor know if you take other medicines, including supplements or herbal products.